A natural brassinosteroid and a series of synthetic derivatives were found
to be good inhibitors of herpes simplex virus type 1 (HSV-1) and arenavirus
replication in cell culture. The synthetic compounds tested were analogues
of the 24(S) ethylbrassinone. Compounds (22R,23R,24S)-2 alpha, 3 alpha,5 a
lpha,22,23-pentahydroxystigmastan-6-one and (22R,23R,24S)-3 beta-bromo-5 al
pha,22,23-trihydroxy stigm-astan-6-one were cytotoxic at concentrations of
20-40 mu M. (22S,23S,24S)-2 alpha,3 alpha,22,23-tetrahydroxy-5 alpha,stigma
stan-6-one, (22R,23R,24S)-3 beta-acetoxy-22,23-dihydroxy-5 alpha-cholestan-
6-one, (22S,23S,24S)-3 beta-bromo-22,23-dihydroxy-5 alpha-chol-estan-6-one
and (22S,23S,24S)-3 beta-bromo-5 alpha,22,23-trihydroxy-stigmastan-6-one we
re the most active of the series against HSV-1, with selectivity index (SI)
values (CC50/EC50) ranging from 10.6 to 16.5. The majority of the compound
s were potent inhibitors of arenaviruses, (22S,23S,24S)-3 beta-bromo-5 alph
a,22,23-trihydroxy-stig-mastan-6-one being the most active, with SI values
of 307.8 and 692.5 far Tacaribe and Junin viruses, respectively. The antivi
ral activity of brassinosteroid derivatives was not because of direct inact
ivation; time-of-addition experiments suggested that a late step in HSV-1 m
ultiplication was affected, whereas arenaviruses remained susceptible to th
e compounds throughout the replicative cycle.